Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease

Acta Cardiologica

Volumn 63, Issue 4, 2008, Pages 467-471

  Akgullu, Cagdas ^a   Ozdemir, Bulent ^a   Yilmaz, Yusuf ^a   Kazazoglu, Ali Riza ^a   Aydinlar, Ali ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Arterial elasticity; Coronary artery disease; Statins

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DYSLIPIDEMIA; ELASTICITY; ELASTOGRAPHY; FEMALE; HUMAN; INTENSIVE CARE; LIPID BLOOD LEVEL; MALE; TREATMENT DURATION;

CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; ELASTICITY; FEMALE; HEALTH STATUS INDICATORS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PYRROLES; RISK FACTORS; VASCULAR RESISTANCE;

EID: 52249102849     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.4.2033045     Document Type: Article

References (26)

1. Zoungas S, Asmar RP. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol 2007; 34: 647-51.
2. Blacher J, Safar ME. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract Cardiovasc Med 2005; 2: 450-5.
3. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184-89.
4. Duprez DA, Cohn JN. Arterial stiffness as a risk factor for coronary atherosclerosis. Curr A theroscler Rep 2007; 9: 139-44.
5. Kingwell BA, Ahimastos AA. Arterial stiffness and coronary ischemic disease. Adv Cardiol 2007; 44: 125-38.
6. Ii M, Losordo DW. Statins and the endothelium. Vascul Pharmacol 2007; 46: 1-9.
7. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial function, arterial stiffness and lipid lowering drugs. Expert Opin Ther Targets 2007; 11: 1143-60.
8. Dilaveris P, Giannopoulos G, Riga M, Synetos A, Stefanadis C. Beneficial effects of statins on endothelial dysfunction and vascular stiffness. Curr Vasc Pharmacol 2007; 5: 227-37.
9. Saliashvili G, Davis WW, Harris MT, Le NA, Brown WV. Sinivastatin improved arterial compliance in high-risk patients. Vasc Endovascular Surg 2004; 38: 519-23.
10. Pirro M, Schillaci G, Mannarino, MR, Savarese G, Vaudo G, Siepi D, Paltriccia R, Mannarino E. Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutr Metab Cardiovasc Dis 2007; 17: 436-41.
11. Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM, Kingwell BA. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002; 39: 1020-5.
12. Leibovitz E, Hazanov N, Zimlichman R, Shargorodsky M, Gavish D. Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. Am J Hypertens 2001; 14: 1096-8.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
15. Breithaupt-Grögler K, Belz GG. Epidemiology of the arterial stiffness. Pathol Biol (Paris) 1999; 47: 604-13.
16. Sinha AK, Mehta JL. Modulation of atherosclerosis, blood pressure and arterial elasticity by statins. Adv Cardiol 2007; 44: 315-330.
17. Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, Wilkinson IB. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007; 50: 852-858.
18. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-31.
19. Raison J, Rudnichi A, Safar ME. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens 2002; 16: 705-10.
20. Bocan TM, Mazur MJ, Mueller SB, Brown EQ, Sliskovic DR, O'Brien PM, Creswell MW, Lee H, Uhlendorf PD, Roth BD, et al. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation. Atherosclerosis 1994; 111: 127-42.
21. Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001; 103: 276-83.
22. Mach F. Statins as novel immunomodulators: from cell to potential clinical benefit. Thromb Haemost 2003; 90: 607-10.
23. Mach F. Statins as immunomodulatory agents. Circulation 2004; 109: II15-7.
24. Goligorsky MS. Clinical assessment of endothelial dysfunction: combine and rule. Curr Opin Nephrol Hypertens 2006; 15: 617-24.
25. DeLoach SS, Townsend RR. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 2008; 3: 184-92.
26. Hueb W, Soares PR, Gersh BJ, César LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JA. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004; 43: 1743-51.